Namaste Technologies (TSXV:N) signed a software services agreement with Indigenous Canadian Medical Dispensaries, a group looking to give healthcare to Indigenous communities.
As quoted in the press release:
Under the terms of the Agreement, NamasteMD will provide IcMD with exclusive access to its online platform for Indigenous people across Canada, via both desktop and mobile phone platforms, on both Apple iOS and Android devices. In turn, IcMD has agreed to offer NamasteMD exclusivity for all its online patient consultations across Canada. As part of the Agreement, Namaste will use a unique code for IcMD to track patient acquisition from IcMD’s channels, and will offer medical cannabis, pharmaceutical products, as well as medical devices.
Christopher Henry, CEO of IcMD comments: “By partnering with Namaste Technologies and NamasteMD we are able to gain access to technology that would allow us to realize our dream of putting healthcare in the hands of the people. This has the potential to change how we provide healthcare to Indigenous communities across Canada and bring them one more step to equality with all Canadians.”
American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.
Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.
Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).